Bispecific antibody therapy
A fact sheet on bispecific antibody therapy for people with haemophilia, their families and carers.
It explains what bispecific antibody therapies are, how they work, who they are for and how they are given. It also covers treatment safety (side-effects and anti-drug antibodies) and living well with treatment. Includes a diagram that explains the action of a bispecific antibody.
(October 2025)
Download fact sheet PDF 931 KB
Acknowledgments
This fact sheet has been funded by unrestricted education grants from CSL Behring and Sanofi. This funding is based on a mutual understanding that HFA will act independently for the benefit of the bleeding disorders community. HFA does not promote any particular pharmaceutical product. Where possible products are referred to by their class or generic name and any mention of any commercial brand is strictly for educational purposes.